At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy. [electronic resource]
Producer: 20130905Description: 25-39 p. digitalISSN:- 1938-3673
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
There are no comments on this title.
Log in to your account to post a comment.